Topline Capital Management LLC bought a new position in shares of MultiPlan Co. (NYSE:MPLN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 321,698 shares of the company's stock, valued at approximately $4,755,000. MultiPlan comprises 0.9% of Topline Capital Management LLC's investment portfolio, making the stock its 21st largest position. Topline Capital Management LLC owned 1.99% of MultiPlan at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in MPLN. Beach Point Capital Management LP increased its position in MultiPlan by 9.2% in the 4th quarter. Beach Point Capital Management LP now owns 384,982 shares of the company's stock valued at $5,690,000 after acquiring an additional 32,582 shares in the last quarter. Prudential Financial Inc. acquired a new stake in shares of MultiPlan in the 4th quarter valued at $2,494,000. RBF Capital LLC raised its position in shares of MultiPlan by 62.3% during the fourth quarter. RBF Capital LLC now owns 147,051 shares of the company's stock worth $2,173,000 after acquiring an additional 56,470 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of MultiPlan by 17.3% during the fourth quarter. Geode Capital Management LLC now owns 67,615 shares of the company's stock valued at $1,000,000 after acquiring an additional 9,954 shares during the period. Finally, Empowered Funds LLC boosted its holdings in MultiPlan by 5.0% in the fourth quarter. Empowered Funds LLC now owns 46,191 shares of the company's stock valued at $683,000 after acquiring an additional 2,188 shares during the last quarter. 87.15% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Separately, Citigroup upped their target price on shares of MultiPlan from $10.00 to $12.50 and gave the company a "neutral" rating in a research report on Friday, January 10th.
Get Our Latest Research Report on MPLN
MultiPlan Trading Up 2.7 %
Shares of NYSE:MPLN traded up $0.61 during midday trading on Wednesday, hitting $23.02. The company had a trading volume of 44,691 shares, compared to its average volume of 114,351. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 21.73. MultiPlan Co. has a 12 month low of $4.80 and a 12 month high of $31.01. The firm has a fifty day simple moving average of $20.85 and a 200 day simple moving average of $15.53. The stock has a market cap of $372.26 million, a price-to-earnings ratio of -0.24 and a beta of 0.13.
MultiPlan Profile
(
Free Report)
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
Featured Articles

Before you consider MultiPlan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.
While MultiPlan currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.